tiprankstipranks
Trending News
More News >
Fresenius Medical Care Corp. (FMS)
NYSE:FMS
US Market

Fresenius Medical Care (FMS) Earnings Dates, Call Summary & Reports

Compare
336 Followers

Earnings Data

Report Date
Aug 05, 2025
TBA Not Confirmed
Period Ending
2025 (Q2)
Consensus EPS Forecast
0.49
Last Year’s EPS
0.38
Same Quarter Last Year
Based on 3 Analysts Ratings

Earnings Call Summary

Earnings Call Date:May 06, 2025
|
% Change Since: 7.72%
|
Next Earnings Date:Aug 05, 2025
Earnings Call Sentiment|Positive
The earnings call highlighted strong organic revenue growth, operational income growth, and improved margins, particularly in the Care Enablement segment. However, challenges such as the severe flu season, one less dialysis day, and portfolio optimization impacts were noted. Despite these challenges, the company remains confident in its full-year 2025 outlook.
Company Guidance
During the first quarter of 2025, Fresenius Medical Care reported several key performance metrics, indicating a strong start to the year and alignment with their strategic plan. The company achieved 5% organic revenue growth, with significant contributions from both Care Delivery and Care Enablement segments. The FME25 transformation program continued to yield results, delivering €68 million in additional sustainable savings towards the targeted €180 million for the year. Operating income grew by 11%, consistent with the company's full-year outlook, and the net leverage ratio improved to 2.8 times. Despite challenges such as a severe flu season, the company maintained stable same market treatment growth in the U.S. and strong same market treatment growth of 2.5% in international markets. The Care Enablement margin improved to 8.3%, entering its target margin band of 8% to 12%. The company confirmed its full-year outlook, expecting positive to low single-digit revenue growth and operating income growth in the high teens to high 20s percent range.
Strong Organic Revenue Growth
The company reported strong organic revenue growth of 5% in Q1 2025, with positive contributions from both Care Delivery and Care Enablement segments.
Operational Income Growth and Savings
Achieved 11% operating income growth, consistent with the expected phasing of the full-year outlook. Delivered €68 million in additional sustainable savings as part of the FME25 transformation program.
Improved Net Leverage Ratio
The net leverage ratio improved to 2.8 times, which is well below the self-imposed target range of 3 to 3.5 times, thanks to robust cash flow development and strict financial discipline.
Care Enablement Margin Improvement
The Care Enablement segment margin improved to 8.3%, entering its target margin band of 8% to 12% for the first time, driven by solid volume growth and positive pricing momentum.
Positive Outlook for 2025
The company confirmed its full-year outlook for 2025, expecting operating income to grow by a high teens to high 20s percent rate compared to the prior year.

Fresenius Medical Care (FMS) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

FMS Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Aug 05, 2025
2025 (Q2)
0.49 / -
0.378
May 06, 2025
2025 (Q1)
0.43 / 0.48
0.36131.86% (+0.11)
Feb 25, 2025
2024 (Q4)
0.42 / 0.48
0.4760.42% (<+0.01)
Nov 05, 2024
2024 (Q3)
0.38 / 0.45
0.30347.52% (+0.14)
Jul 30, 2024
2024 (Q2)
0.37 / 0.38
0.32217.39% (+0.06)
May 07, 2024
2024 (Q1)
0.28 / 0.36
0.29124.05% (+0.07)
Feb 20, 2024
2023 (Q4)
0.44 / 0.48
0.4564.39% (+0.02)
Nov 01, 2023
2023 (Q3)
0.29 / 0.30
0.403-24.81% (-0.10)
Aug 02, 2023
2023 (Q2)
0.29 / 0.32
0.393-18.07% (-0.07)
May 09, 2023
2023 (Q1)
0.24 / 0.29
0.359-18.94% (-0.07)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

FMS Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
May 06, 2025
$25.14$26.90+7.00%
Feb 25, 2025
$22.87$23.01+0.61%
Nov 05, 2024
$19.67$19.95+1.42%
Jul 30, 2024
$19.98$19.26-3.60%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Fresenius Medical Care Corp. (FMS) report earnings?
Fresenius Medical Care Corp. (FMS) is schdueled to report earning on Aug 05, 2025, TBA Not Confirmed.
    What is Fresenius Medical Care Corp. (FMS) earnings time?
    Fresenius Medical Care Corp. (FMS) earnings time is at Aug 05, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is FMS EPS forecast?
          FMS EPS forecast for the fiscal quarter 2025 (Q2) is 0.49.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis